找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Exon Skipping and Inclusion Therapies; Methods and Protocol Toshifumi Yokota,Rika Maruyama Book 2018 Springer Science+Business Media, LLC,

[复制链接]
楼主: 短暂
发表于 2025-3-30 08:32:22 | 显示全部楼层
发表于 2025-3-30 14:17:33 | 显示全部楼层
发表于 2025-3-30 18:12:01 | 显示全部楼层
发表于 2025-3-30 21:21:20 | 显示全部楼层
发表于 2025-3-31 03:51:18 | 显示全部楼层
J. Nagarjun,S. Manimaran,M. Krishnaprakash patient to myotubes by MyoD transduction using fluorescence-activated cell sorting (FACS). We subsequently designed antisense PMOs targeting identical regions of dog and human dystrophin exons 6 and 8 and administered them as a cocktail to the in vitro generated dog or human myotubes. In both cases
发表于 2025-3-31 07:36:45 | 显示全部楼层
https://doi.org/10.1007/978-3-540-88087-5tiated myoblasts. Herein, we describe an optimized methodology to prepare myoblasts differentiated from iPS cells by mRNA transfection of the CRISPR-Cas9 system to skip exon 45 in myoblasts, and evaluate the restored dystrophin by RT-PCR and Western blotting.
发表于 2025-3-31 09:56:28 | 显示全部楼层
发表于 2025-3-31 16:13:07 | 显示全部楼层
发表于 2025-3-31 19:11:03 | 显示全部楼层
发表于 2025-4-1 00:29:22 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-7 05:08
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表